NVNehal P. Vadhan

Nehal P. Vadhan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nehal P. Vadhan has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mothers in Substance Use Treatment: Demographic and Clinical Trends Among Outpatients from 2005 to 2025

    by Monica Tomlinson, Simran Bhola, Nehal P. Vadhan, Jared Weiss, Andrew Benevento

    Introduction: Over the last 20 years, maternal mental health has rapidly declined in the United States, and substance use among mothers has increased. As awareness of substance use in this population grows, more screening and referral programs are being implemented into primary care settings to connect mothers with specialized treatment. It is unclear whether these policies have contributed to an overall increase in admissions for this population. This information, as well as demographic and clinical information about these admissions, would assist programs in meeting the needs of mothers struggling with substance use disorders (SUDs). This project examines outpatient SUD treatment utilization among mothers from 2005-2025, employing a serial cross-sectional design to assess demographic (e.g., race, age) and clinical (e.g., diagnosis) profiles of mothers. Method: Admission encounters (3,663) within five outpatient SUD programs were analyzed across four time periods (2005-2009, 2010-2014, 2015-2019, 2020-2025) to assess these variables. Results: Distributions of all variables significantly differed across time periods (P < .05), except history of psychiatric hospitalization and pregnancy at admission. Maternal admissions increased from n = 775 (2005-2009) to n = 1,297 (2020-2025). Primary alcohol use soared from 38% to 60%. Admissions with co-existing psychiatric disorders significantly increased from 49% to 57%. Medical and mental health provider referrals increased, and social services and justice referrals decreased. Conclusion: Data suggest that mothers in treatment have evolved from a vulnerable, often mandated, population to a more diverse, self-referred group with complex co-occurring conditions. Specialized treatment programs are encouraged to provide dual-diagnosis treatment focusing on alcohol use for mothers. Programs are also encouraged to further explore reasons why more vulnerable populations (e.g., African American, low income, unemployed), are less likely to seek outpatient SUD treatment in the last decade. See Figure 1 for a graphical

  • Open Access

    Decisional incentive sensitivity is linked to contingency management outcome and striatal dopamine signaling in individuals with cocaine use disorder: a preliminary study

    by Nehal P. Vadhan, Kenneth M. Carpenter, Elysia Benedict, Catherine E. Myers, Mark A. Gluck, Diana Martinez, Edward V. Nunes

    Background: Nontreatment-seeking individuals with cocaine use disorder (CUD) have been found to exhibit decision-making on laboratory tasks that is risky but also sensitive to monetary incentive, relative to controls. Objective: The purpose of this study was to replicate these findings in treatment-seeking individuals and explore their relationships with voucher-based treatment outcome and striatal dopamine (DA) release. Methods: This study was approved by the Institutional Review Board, and all participants provided written informed consent to participate. Eighteen briefly-abstinent individuals seeking treatment for CUD and 19 control participants were compared on performance of a modified Iowa Gambling task (mIGT) under both hypothetical and cash earning conditions. The CUD participants subsequently received Positron Emission Tomography (PET) scans with [11C]raclopride with methylphenidate (60 mg) challenge and then 12 weeks of Community Reinforcement Approach plus Vouchers (CRA+V) treatment. Results: On the mIGT, the CUD participants’ advantageous card selection was selectively more sensitive to the presence of a monetary incentive, relative to controls (F4,128 = 3.10, p<0.05). Among the male CUD participants, those who exhibited greater DA release in the ventral striatum (VSt), and those who responded to the CRA+V treatment, exhibited greater mIGT incentive sensitivity than those who were nonresponders (F4,44 = 5.84, p<0.01), and who exhibited relatively decreased VSt DA release (F4,48 = 2.55, p<0.05). Conclusions: Participants seeking treatment for CUD exhibited selectively increased decisional incentive sensitivity, relative to controls. For the male CUD participants, greater incentive sensitivity was associated with greater VSt DA release and better CRA+V outcome. These findings appear partially consistent with previous findings on cognition and motivation in individuals with CUD, and suggest a heuristic model connecting striatal DA, incentive sensitivity, and CRA+V outcome.

  • An exploratory study of adaptive brief interventions for alcohol use among non-specialty treatment seeking volunteers: The moderating effect of age

    by Alexis Kuerbis, Silke Behrendt, Simone Schultz, Julie Glickman, Svetlana Levak, Nehal P. Vadhan, Jon Morgenstern

  • Open Access

    Impulsive responding increases during a laboratory model of a cocaine binge in individuals who use cocaine: A preliminary study

    by Nehal P. Vadhan, Sean P. Madden, Majnu John, Stephanie Collins Reed, Suzanne K. Vosburg, John G. Keilp, Richard W. Foltin

    Background: Individuals with a binge pattern of cocaine use have been found to exhibit cognitive decrements relative to controls, but also experience increases in cognitive performance during binge cocaine administration in the laboratory. Objective: We examined cognitive performance during binge cocaine administration in the laboratory, but with varied amounts of cocaine, to better estimate its cognitive effects in the natural ecology. Methods: This study was approved by the Institutional Review Board of the New York State Psychiatric Institute, and all participants provided written informed consent to participate. Twelve individuals who used cocaine regularly (males=91.7%) and were physically/psychiatrically – healthy, completed a nightly counterbalanced cognitive battery during 2 phases of cocaine administration, separated by a period of cocaine abstinence (all phases maximum 5 days each). During cocaine phases, participants smoked cocaine up to 12 times per day (25 mg per occasion) as part of an experimenter-administered or self-administered protocol. Results: On average, participants exhibited decreased attentional response inhibition (F(2,48)=12.70, p<0.05) during Binge 1 (M=1072.5 mg cocaine), relative to Abstinence (0.0 mg cocaine) and Binge 2 (M=650.0 mg cocaine). The self-administration group exhibited decreased motor tracking (F=6.11(1,12.4), p<0.05) during Binge 2, relative to the other study phases, whereas the experimenter-administration group did not. Conclusions: These data suggest that response inhibition, but not immediate memory or psychomotor speed, was impaired during periods of binge cocaine administration in experienced users. This finding has important implications for behaviors that require inhibitory control, such as driving, during cocaine intoxication.


  • Correlates of length of stay in a short‐term inpatient residential addiction treatment facility

    by Jessica L. Bourdon, Sabrina Verdecanna, Jordan Wright, Nehal P. Vadhan, Monica F. Wright, Jon Morgenstern

    Background: There is a gap in the extant literature regarding length of stay (LOS) in short‐term inpatient addiction treatment facilities. Furthermore, there is a lack in focus on treatment factors which may be better indicators for positive patient outcomes than demographic profiles. The current study sought to examine modifiable correlates of LOS within a short‐term inpatient residential facility to extend LOS and improve patient outcomes.Methods: N = 792 participants who completed a baseline assessment and either completed treatment or left against clinical advice were included in the sample. Outcomes of interest were self‐efficacy (domains included negative affect, pro‐social or positive use, physical discomfort, withdrawal, or urges), well‐being (domains included symptom distress, interpersonal relations, and social role), and social network size.Results: Baseline dysfunctional social role, larger social network size, and higher alcohol use disorder (AUD) severity all led to increases in LOS. No aspects of self‐efficacy, symptom distress, interpersonal relatedness, substance use disorder (SUD) severity, nor other demographic variables were associated with LOS.Conclusions: This study highlights the importance of taking steps to improve self‐perceived social role and social network size. Given that the purpose of this study was to determine modifiable correlates of LOS, we suggest that clinicians at inpatient, short‐term addiction treatment centers adopt thorough measures of well‐being and social network to support patient treatment and recovery.


  • Open Access

    Self‐reported alcohol consumption during participation in a text messaging‐based online drinking moderation platform

    by Nehal P. Vadhan, Hayley Treloar Padovano, Frederick J. Muench, Svetlana Levak, Nicholas Allen

    Background: Many individuals with excessive alcohol consumption desire moderation but do not seek formalized treatment. Commercially available, technology‐assisted options are flexible and highly accessible, yet often not empirically validated.Methods: Individuals desiring alcohol moderation (age 21+) self‐selected to use Sunnyside®, a web application with tailored and adaptive text messaging. The evaluable dataset included 46,411 members who completed a baseline assessment, enrolled in the program, and tracked their drinking at least once. An adaptive and customizable weekly plan was generated from typical drinking patterns, goals, and weekly reported progress. Personalized daily messages included reminders for real‐time drink tracking, plans, and available interactive messaging with peer coaches. Generalized mixed‐effect growth models characterized change in drinks per week and daily drinking for 12 weeks after enrollment. Models allowed for nonlinear change and individual variability across members and weeks.Results: A majority (64.3%) of members reported typically drinking 7 of 7 days per week at baseline. During tracking, drinks per week decreased most in the initial weeks and slowed thereafter, with an overall 33% reduction in weekly drink counts. More severe alcohol‐use patterns and concern over drinking at baseline were associated with greater relative benefit.Conclusions: Drinking patterns appeared amenable to change during 12 weeks of daily drink tracking with Sunnyside®, a tailored web program to reduce drinking and improve overall wellness. Overall, the findings of this naturalistic study, one of the first of its kind, supplement data from randomized clinical trials and support the use of adaptive, technology‐assisted tools for alcohol moderation.


  • Open Access

    MDMA for the Treatment of Negative Symptoms in Schizophrenia

    by Mitchell D. Arnovitz, Andrew J. Spitzberg, Ashkhan J. Davani, Nehal P. Vadhan, Julie Holland, John M. Kane, Timothy I. Michaels

    The profound economic burden of schizophrenia is due, in part, to the negative symptoms of the disease, which can severely limit daily functioning. There is much debate in the field regarding their measurement and classification and there are no FDA-approved treatments for negative symptoms despite an abundance of research. 3,4-Methylenedioxy methamphetamine (MDMA) is a schedule I substance that has emerged as a novel therapeutic given its ability to enhance social interactions, generate empathy, and induce a state of metaplasticity in the brain. This review provides a rationale for the use of MDMA in the treatment of negative symptoms by reviewing the literature on negative symptoms, their treatment, MDMA, and MDMA-assisted therapy. It reviews recent evidence that supports the safe and potentially effective use of MDMA to treat negative symptoms and concludes with considerations regarding safety and possible mechanisms of action.


  • Open Access

    The role of daily goal setting among individuals with alcohol use disorder

    by Hayley Treloar Padovano, Svetlana Levak, Nehal P. Vadhan, Alexis Kuerbis, Jon Morgenstern


  • Open Access

    Smoked Cannabis Effects in Cannabis Users at Clinical High-Risk for Psychosis: A Further Investigation of Cognition and Reward

    by Sean Madden, John Keilp, Olivia Wu, Cheryl Corcoran, Ragy Girgis, Nehal Vadhan

    Objective. Some adverse cannabis effects are greater in individuals on the psychosis spectrum compared to healthy individuals. We have previously reported that smoked cannabis acutely worsened psychotic-like states and reduced cognitive performance selectively in cannabis users at clinical high-risk (CHR) for psychosis. The objective of the present study was to further investigate the acute effects of cannabis on cognition and reward processing in CHR cannabis users. Method. Six CHR cannabis users and six psychiatrically-healthy cannabis users comparable in intellectual, demographic, and cannabis use characteristics (including nontreatment-seeking status), participated in the study. Objective and subjective measures of cognition and cannabis reward, were completed before and after smoking half of an active (5.5% Δ9tetrahydrocannabinol [Δ9-THC]) or half of a placebo (0.0% Δ9-THC) cannabis cigarette, under randomized/double-blind conditions. Repeated measures ANOVA tested main effects of drug condition (active vs. placebo) and/or the drug condition × time (baseline vs. post-administration) interactions; groups were analyzed separately due to the small sample size. Results. CHR participants exhibited evidence of decreased objective response inhibition and aversive intoxication following active cannabis, relative to placebo. Psychomotor speed and cannabis-related attentional bias were also affected by cannabis intoxication. No such effects were observed in psychiatrically-healthy cannabis users. Conclusion. These findings provide further preliminary evidence of a deleterious cognitive and reward-related response to cannabis in individuals with preexisting risk for psychosis.


  • An efficacy trial of adaptive interventions for alcohol use disorder

    by Jon Morgenstern, Alexis Kuerbis, Sijing Shao, Hayley Treloar Padovano, Svetlana Levak, Nehal P. Vadhan, Kevin G. Lynch